相关实验视频

Updated: Jul 16, 2025

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

骨质疏松症在非特定[¹⁸F]PSMA-1007骨吸收中的潜在作用

Gaia Ninatti^1,2, Cristiano Pini^3,4, Fabrizia Gelardi^5,6

¹Nuclear Medicine Department, IRCCS San Raffaele Scientific Institute, Milan, Italy.

European journal of nuclear medicine and molecular imaging

|September 12, 2023

概括

在[18F]PSMA-1007 PET成像中观察到超过三分之一的前列腺癌患者的非特异性骨吸收. 这种吸收可能与骨质疏松症有关,与血液细胞计数和较低的骨密度有关.

科学领域:

核医学就是核医学.
放射性药物放射性药物放射性药物
在瘤学瘤学.

背景情况:

不特定的骨吸收是PSMA向放射性药物的限制,如PET成像中的[18F]PSMA-1007.
调查这种不特定吸收的原因对于提高诊断准确性至关重要.

研究的目的:

探索骨质疏松症与非特定[18F]PSMA-1007骨吸收之间的联系.
在接受[18F]PSMA-1007PET扫描的患者中识别与骨矿物质密度相关的潜在标志物.

主要方法:

77名未接受过治疗的前列腺腺癌患者的回顾性分析,这些患者接受了[18F]PSMA-1007 PET分期.
由三个核医学医生进行的定性图像分析,以确定不特定的骨吸收.
在有或没有非特异性摄取的患者之间比较临床参数,血细胞计数,BMI和骨密度.

主要成果:

38%的患者有非特异性骨吸收,主要发生在骨盆骨和肋骨中.
两组之间没有发现临床参数的显著差异.
不特定吸收患者的白细胞和中性粒细胞数量较高,BMI和骨密度较低 (不具有统计学意义).

结论:

超过三分之一的患者在[18F]PSMA-1007 PET.上表现出不特定的骨吸收.
在血清参数和不特定的骨吸收之间发现了显著的相关性.
这些发现表明[18F]PSMA-1007非特异性骨吸收和骨质疏松症之间存在潜在联系,需要在更大的队列中进一步调查.

关键词:

骨吸收的时间骨质疏松症是一种骨质疏松症.聚乙烯/聚乙烯/聚乙烯有关PET/MRI的研究.在PSMA上,PSMA可以在PSMA上进行交易.前列腺癌是什么意思前列腺癌是什么意思 [18F]PSMA-1007是不是可以使用?

更多相关视频

Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain

Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain

Published on: August 8, 2019

Cortical Bone Assessment Using Ultrasonic Guided Waves: A Reproducibility Study in a Healthy Population

Cortical Bone Assessment Using Ultrasonic Guided Waves: A Reproducibility Study in a Healthy Population

Published on: January 31, 2025

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...